Prazma CM - Search Results

1

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators. Bel EH, et al. Among authors: prazma cm. N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199060 Free article. Clinical Trial.

2

Characterisation of an OCS-dependent severe asthma population treated with mepolizumab.

Prazma CM, Wenzel S, Barnes N, Douglass JA, Hartley BF, Ortega H. Prazma CM, et al. Thorax. 2014 Dec;69(12):1141-2. doi: 10.1136/thoraxjnl-2014-205581. Epub 2014 May 16. Thorax. 2014. PMID: 24834924 Clinical Trial.

3

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment.

Magnan A, Bourdin A, Prazma CM, Albers FC, Price RG, Yancey SW, Ortega H. Magnan A, et al. Among authors: prazma cm. Allergy. 2016 Sep;71(9):1335-44. doi: 10.1111/all.12914. Epub 2016 May 24. Allergy. 2016. PMID: 27087007 Free PMC article.

4

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.

Prazma CM, Bel EH, Price RG, Bradford ES, Albers FC, Yancey SW. Prazma CM, et al. Respir Res. 2019 May 3;20(1):83. doi: 10.1186/s12931-019-1056-4. Respir Res. 2019. PMID: 31053134 Free PMC article. Clinical Trial.

5

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions.

Gibson PG, Prazma CM, Chupp GL, Bradford ES, Forshag M, Mallett SA, Yancey SW, Smith SG, Bel EH. Gibson PG, et al. Among authors: prazma cm. Respir Res. 2021 Jun 7;22(1):171. doi: 10.1186/s12931-021-01746-4. Respir Res. 2021. PMID: 34098955 Free PMC article. Review.

6

Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.

Sehmi R, Smith SG, Kjarsgaard M, Radford K, Boulet LP, Lemiere C, Prazma CM, Ortega H, Martin JG, Nair P. Sehmi R, et al. Among authors: prazma cm. Clin Exp Allergy. 2016 Jun;46(6):793-802. doi: 10.1111/cea.12695. Clin Exp Allergy. 2016. PMID: 26685004

7

Rigor Is Needed When Making Comparative Analyses of Biologics in Severe Asthma.

Prazma CM, Katial R, Howarth P, Bradford E, Martin N, Pizzichini E. Prazma CM, et al. Am J Respir Crit Care Med. 2018 Jun 1;197(11):1508-1510. doi: 10.1164/rccm.201712-2455LE. Am J Respir Crit Care Med. 2018. PMID: 29360390 No abstract available.

8

Update on immunogenicity in severe asthma: Experience with mepolizumab.

Ortega HG, Meyer E, Brusselle G, Asano K, Prazma CM, Albers FC, Mallett SA, Yancey SW, Gleich GJ. Ortega HG, et al. Among authors: prazma cm. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2469-2475.e1. doi: 10.1016/j.jaip.2019.03.042. Epub 2019 Apr 5. J Allergy Clin Immunol Pract. 2019. PMID: 30954640 Free article. Clinical Trial. No abstract available.

9

Association of depressive symptoms with health status and markers of uncontrolled severe asthma.

Khurana S, Lyness JM, Mallett S, Nelsen LM, Prazma CM, Albers FC, Forshag M, Llanos JP, Yancey SW, Ortega HG. Khurana S, et al. Among authors: prazma cm. Allergy Asthma Proc. 2019 Jul 1;40(4):230-239. doi: 10.2500/aap.2019.40.4229. Allergy Asthma Proc. 2019. PMID: 31262378 Clinical Trial.

10

Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use.

Albers FC, Hozawa S, Bratton DJ, Yancey SW, Prazma CM, Humbert M, Liu MC. Albers FC, et al. Among authors: prazma cm. Allergy. 2020 Apr;75(4):942-946. doi: 10.1111/all.14048. Epub 2019 Oct 2. Allergy. 2020. PMID: 31520471 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page